These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16781825)

  • 1. Can phenytoin prevent Alzheimer's disease?
    Dhikav V
    Med Hypotheses; 2006; 67(4):725-8. PubMed ID: 16781825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is hippocampal atrophy a future drug target?
    Dhikav V; Anand KS
    Med Hypotheses; 2007; 68(6):1300-6. PubMed ID: 17098374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids may initiate Alzheimer's disease: a potential therapeutic role for mifepristone (RU-486).
    Dhikav V; Anand KS
    Med Hypotheses; 2007; 68(5):1088-92. PubMed ID: 17107752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease.
    deToledo-Morrell L; Stoub TR; Wang C
    Prog Brain Res; 2007; 163():741-53. PubMed ID: 17765748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
    Bethmann K; Brandt C; Löscher W
    Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal shape analysis in Alzheimer's disease: a population-based study.
    Scher AI; Xu Y; Korf ES; White LR; Scheltens P; Toga AW; Thompson PM; Hartley SW; Witter MP; Valentino DJ; Launer LJ
    Neuroimage; 2007 May; 36(1):8-18. PubMed ID: 17434756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium may be useful in the prevention of Alzheimer's disease in individuals at risk of presenile familial Alzheimer's disease.
    Yeh HL; Tsai SJ
    Med Hypotheses; 2008 Dec; 71(6):948-51. PubMed ID: 18760542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and protective factors for sporadic Alzheimer's disease.
    Stozická Z; Zilka N; Novák M
    Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease.
    Geerlings MI; den Heijer T; Koudstaal PJ; Hofman A; Breteler MM
    Neurology; 2008 Apr; 70(15):1258-64. PubMed ID: 18391157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does phenytoin play any role in prevention of Alzheimer's disease?
    Jaseja H
    Med Hypotheses; 2007; 68(3):718-9. PubMed ID: 17011726
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse.
    Chen Q; Nakajima A; Choi SH; Xiong X; Tang YP
    J Neurosci Res; 2008 May; 86(7):1615-25. PubMed ID: 18189321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Glowniak K; Czuczwar SJ
    Eur J Pharmacol; 2007 Nov; 574(2-3):133-9. PubMed ID: 17651727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The coming problem of HIV-associated Alzheimer's disease.
    Alisky JM
    Med Hypotheses; 2007; 69(5):1140-3. PubMed ID: 17433562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cholinergic status in hippocampus produces spatial memory deficits when combined with kainic acid induced seizures.
    Craig LA; Hong NS; Kopp J; McDonald RJ
    Hippocampus; 2008; 18(11):1112-21. PubMed ID: 18651618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
    Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
    Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal volume and cortical sources of EEG alpha rhythms in mild cognitive impairment and Alzheimer disease.
    Babiloni C; Frisoni GB; Pievani M; Vecchio F; Lizio R; Buttiglione M; Geroldi C; Fracassi C; Eusebi F; Ferri R; Rossini PM
    Neuroimage; 2009 Jan; 44(1):123-35. PubMed ID: 18805495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.